LifeShield™ Neutron™ Catheter Patency Device

It’s Time to Stop Blood Reflux from Complicating IV Therapy

Neutron Product Photo 248x150With over 250,000 catheter-related bloodstream infections occurring annually1, the LifeShield™ Neutron™ needle-free catheter patency device helps reduce the opportunity for infection. This innovative device helps to improve the patient experience by minimizing the risk of occlusions and the costs associated with resolving them, including:

  • Delays in therapy with critical IV medications2
  • Discomfort caused by corrective steps necessary to restore catheter patency3,4
  • Risks associated with use of declotting agents such as tissue plasminogen activator (t-PA)5,6
  • Flushing of the line, which could release part of a thrombus into the bloodstream7,8
  • The need for heparin (hep lock) in flush and lock solutions9

The LifeShield Neutron’s unique design helps protect against the risk of infection.

IV Sets LS Neutron Middle Graphic 630x299 

Help enhance care and optimize patient safety with the Hospira LifeShield Neutron device. For more information, contact your Hospira sales representative or call us at 1-877-946-7747.

1. Guidelines for the prevention of intravascular catheter-related bloodstream infections, 2011. Centers for Disease Control and Prevention Web site. www.cdc.gov/hicpac/BSI/BSI-guidelines-2011.html. Accessed September 19, 2012.
2. Wingerter L. Vascular access device thrombosis. Clin J Oncol Nurs. 2003;7(3):345-348.
3. Data on file, Hospira, Inc. Keeping the lines open with evidence-based practice and advanced technologies. Schallom L. 2008.
4. Hadaway LC. Reopen the pipeline for I.V. therapy. Nursing. 2005;35(8):54-61.
5. Kerner JA, Garcia-Careaga MG, Fisher AA, Poole RL. Treatment of catheter occlusion in pediatric patients. J Parenter Enteral Nutr. 2006;30(1 suppl.):S73-S81.
6. Activase [package insert]. San Francisco, CA: Genetech, Inc.; 2011.
7. Hadaway LC. Reopen the pipeline for I.V. therapy. Nursing. 2005;35(8):54-61.
8. Macklin D. Catheter management. Semin Oncol Nurs. 2010;26(2):113-120.
9. Boersma RS, Jie KSG, Verbon A, van Pampus ECM, Schouten HC. Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol. 2008;19(3):433-442.
10. Data on file. ICU Medical, Inc. MI-1304.
11. Data on file, ICU Medical, Inc. Neutron 510(k)
12. Bouza E, Muñoz P, López-Rodríguez J, et al. A needleless closed system device (CLAVE) protects from intravascular catheter tip and hub colonization: a prospective randomized study. J Hosp Infect. 2003;54(4):279-287.
13. Data on file, Hospira, Inc. Keeping the lines open with evidence-based practice and advanced technologies, Schallom L. 2008